BRIEF published on 07/21/2025 at 20:57, 10 months 11 days ago Advicenne raises 2.6 million euros to strengthen its financial capacity Capital Increase Financial Market Bpifrance Kidney Diseases Advicenna
BRIEF published on 03/27/2025 at 19:17, 1 year 2 months ago Advicenne Reports Solid Growth and Future Plans for 2025 Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress
PRESS RELEASE published on 03/27/2025 at 19:12, 1 year 2 months ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
BRIEF published on 10/01/2024 at 07:05, 1 year 8 months ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 1 year 8 months ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 2 years ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
PRESS RELEASE published on 05/15/2024 at 09:02, 2 years ago Inside Information / Other news releases Advicenne's Board of Directors' resolutions approved at the Combined General Meeting. Shareholders support all resolutions including financial statements and delegations Board Of Directors Shareholders Financial Statements Combined General Meeting Advicenne
BRIEF published on 05/15/2024 at 08:06, 2 years ago Advicenne launches a share buyback program Share Buyback Euronext Growth Financial Market Advicenne Kidney Diseases
Published on 06/02/2026 at 04:00, 2 hours 23 minutes ago Lobe Sciences Announces Proposed Shares for Debt Transaction
Published on 06/02/2026 at 03:00, 3 hours 23 minutes ago Clean Air Metals Files Audited Annual Financial Statements for the Year Ended January 31, 2026
Published on 06/01/2026 at 23:57, 6 hours 26 minutes ago Metallic Minerals Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$8.0 Million
Published on 06/01/2026 at 23:05, 7 hours 18 minutes ago Faraday Copper Strengthens Team to Support Project Advancement in Arizona
Published on 06/02/2026 at 05:22, 1 hour 1 minute ago Hymson Highlights Operational Reliability at The Battery Show Europe 2026
Published on 06/02/2026 at 03:35, 2 hours 48 minutes ago MSI Showcases Liquid-Cooled AI Infrastructure, NVIDIA MGX, NVIDIA DGX Station and DC-MHS Platforms at COMPUTEX 2026
Published on 06/02/2026 at 03:35, 2 hours 48 minutes ago ASUS Unveils RUC-2000-Series Rugged-Rack Edge AI System at COMPUTEX 2026
Published on 06/02/2026 at 02:15, 4 hours 8 minutes ago At COMPUTEX 2026, YPlasma Unveils the First Fanless Solid-State Cooling for NVIDIA Jetson
Published on 06/02/2026 at 01:50, 4 hours 33 minutes ago Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
Published on 06/01/2026 at 18:47, 11 hours 36 minutes ago Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 12 hours 23 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 12 hours 29 minutes ago Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 12 hours 29 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 12 hours 38 minutes ago ENGIE secures €1 billion export financing backed by Euler Hermes
